Get started
DERMAPHARM HLDG SEDERMAPHARM HLDG SEDERMAPHARM HLDG SE

DERMAPHARM HLDG SE

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

DMP chart


Full chart

DMP upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.83 B‬ CHF
Dividend yield (indicated)
2.47%
Price to earnings Ratio (TTM)
18.143
Basic EPS (TTM)
1.987 CHF
Net income (FY)
‪106.98 M‬ CHF
Revenue (FY)
‪1.11 B‬ CHF
Shares float
‪16.72 M‬
Beta (1Y)
0.48

Employees


Employees (FY)
‪3.6 K‬
Revenue / Employee (1Y)
‪308.37 K‬ CHF
Net income / Employee (1Y)
‪29.72 K‬ CHF

About DERMAPHARM HLDG SE


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Hans-Georg Feldmeier
Website
dermapharm.de
Headquarters
Grunwald
Founded
2017
ISIN
DE000A2GS5D8
FIGI
BBG00LVD7663
Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The company operates through the Branded pharmaceuticals and other healthcare products, Parallel import business and Herbal extracts divisions. Its products include covers prescription pharmaceuticals (Rx), over-the-counter (OTC) products, medical devices, food supplements and cosmetics. The company was founded in 1991 and is headquartered in Grunwald, Germany.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

DMP news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as DMP.

Frequently Asked Questions


The current price of DMP is 33.560 CHF — it has decreased by −6.04% in the past 24 hours. Watch DERMAPHARM HLDG SE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange DERMAPHARM HLDG SE stocks are traded under the ticker DMP.
We've gathered analysts' opinions on DERMAPHARM HLDG SE future price: according to them, DMP price has a max estimate of 66.06 CHF and a min estimate of 41.53 CHF. Watch DMP chart and read a more detailed DERMAPHARM HLDG SE stock forecast: see what analysts think of DERMAPHARM HLDG SE and suggest that you do with its stocks.
DMP reached its all-time high on Sep 28, 2021 with the price of 91.075 CHF, and its all-time low was 31.169 CHF and was reached on Apr 4, 2024. View more price dynamics on DMP chart.
See other stocks reaching their highest and lowest prices.
DMP stock is 6.43% volatile and has beta coefficient of 0.48. Track DERMAPHARM HLDG SE stock price on the chart and check out the list of the most volatile stocks — is DERMAPHARM HLDG SE there?
Today DERMAPHARM HLDG SE has the market capitalization of ‪1.85 B‬, it has decreased by −3.89% over the last week.
Yes, you can track DERMAPHARM HLDG SE financials in yearly and quarterly reports right on TradingView.
DERMAPHARM HLDG SE is going to release the next earnings report on May 15, 2025. Keep track of upcoming events with our Earnings Calendar.
DMP net income for the last quarter is ‪19.28 M‬ CHF, while the quarter before that showed ‪30.56 M‬ CHF of net income which accounts for −36.91% change. Track more DERMAPHARM HLDG SE financial stats to get the full picture.
Yes, DMP dividends are paid annually. The last dividend per share was 0.85 CHF. As of today, Dividend Yield (TTM)% is 2.40%. Tracking DERMAPHARM HLDG SE dividends might help you take more informed decisions.
As of Apr 23, 2025, the company has ‪3.6 K‬ employees. See our rating of the largest employees — is DERMAPHARM HLDG SE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DERMAPHARM HLDG SE EBITDA is ‪290.83 M‬ CHF, and current EBITDA margin is 25.23%. See more stats in DERMAPHARM HLDG SE financial statements.
Like other stocks, DMP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DERMAPHARM HLDG SE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DERMAPHARM HLDG SE technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DERMAPHARM HLDG SE stock shows the sell signal. See more of DERMAPHARM HLDG SE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.